Beijing Science Sun Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 132.7 million compared to CNY 192.1 million a year ago. Revenue was CNY 132.7 million compared to CNY 192.1 million a year ago.

Net income was CNY 0.823935 million compared to CNY 106.55 million a year ago. Basic earnings per share from continuing operations was CNY 0.0017 compared to CNY 0.2212 a year ago. Diluted earnings per share from continuing operations was CNY 0.0017 compared to CNY 0.2212 a year ago.